1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2016

United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 92 pages

Includes 3 FREE quarterly updates

BMI View: The sixth initiative of the UAE's medicine price reduction process will not significantly affectthe country's pharmaceutical market. For drugmakers in the region, lower profit margins will be offset byincreasing sales volumes. The UAE will continue to rely on imported medicines; however, domesticmanufacturing potential will expand over the long term. Fast-track approval times, high affordability levelsand growth of medical tourism will ensure that the UAE remains an attractive destination for multinationalpharmaceutical companies.

Headline Expenditure Projections

- Pharmaceuticals: AED10.77bn (USD2.93bn) in 2015 to AED11.70bn (USD3.19bn) in 2016; +8.6% inlocal currency terms and +8.7% US dollar terms. Forecast revised upwards slightly from last quarter.

- Healthcare: AED54.56bn (USD14.85bn) in 2015 to AED57.81bn (USD15.75bn) in 2016; +6.0% in bothlocal currency and US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United Arab Emirates 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Arab Emirates 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2012-2020) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Arab Emirates 2012-2020) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (United Arab Emirates 2014-2020) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (United Arab Emirates 2014-2020) 32
Industry Risk/Reward Index 33
Middle East and Africa Risk/Reward Index - Q2 2016 33
United Arab Emirates Risk/Reward Index 40
Rewards 40
Risks 40
Regulatory Review 42
Intellectual Property Issues 44
Pricing Regime 47
Market Overview 51
Healthcare Sector 52
Table: Healthcare Resources (United Arab Emirates 2010-2015) 56
Table: Healthcare Personnel (United Arab Emirates 2010-2015) 56
Table: Healthcare Activity (United Arab Emirates 2010-2015) 57
Research and Development 61
Clinical Trials 63
Epidemiology 64
Table: UAE Healthcare Demand Split By Therapeutic Area 66
Competitive Landscape 67
Table: Abu Dhabi's Top Five Best Selling Drugs In Value Terms By Therapeutic Area 67
Foreign Industry 70
Table: Multinational Market Activity 71
Pharmaceutical Distribution and Retail 72
Company Profile 74
Gulf Pharmaceutical Industries (Julphar) 74
Neopharma 78
Demographic Forecast 81
Demographic Outlook 81
Table: Population Headline Indicators (United Arab Emirates 1990-2025) 82
Table: Key Population Ratios (United Arab Emirates 1990-2025) 82
Table: Urban/Rural Population and Life Expectancy (United Arab Emirates 1990-2025) 83
Table: Population By Age Group (United Arab Emirates 1990-2025) 83
Table: Population By Age Group % (United Arab Emirates 1990-2025) 84
Glossary 86
Methodology 88
Pharmaceutical Expenditure Forecast Model 88
Healthcare Expenditure Forecast Model 88
Notes On Methodology 89
Risk/Reward Index Methodology 90
Index Overview 91
Table: Pharmaceutical Risk/Reward Index Indicators 91
Indicator Weightings 92

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.